Welcome to "A Pinch of Salt- A podcast by ERA". Each month, we'll release three episodes with nephrologists and other physicians who have other interests outwith medicine. Hosts: Andrej Skoberne and George KosmadakisAn initiative by ECC – Electronic Communication Committee
The show producer has not yet provided a description for this episode.
1/9/25 • 00:31
The show producer has not yet provided a description for this episode.
1/9/25 • 01:12
The show producer has not yet provided a description for this episode.
1/9/25 • 01:17
Growing up isn’t just about age, it’s about healthcare too! In this episode of A Pinch of Salt, we explore the challenging shift from paediatric to adult nephrology with Arvind Nagra. Learn how to empower young kidney patients to take charge of their health. Check it out!
12/12/24 • 23:21
Navigating through the field of genetics is challenging and something one shouldn't do alone. Check out our episode on genetics and kidney disease with our guest, Emilie Cornec-Le Gall. You can expect to hear about when we should do genetic testing. How do we interpret the results? Do we need a geneticist for the interpretation? What exactly is the variant of unknown significance and much more? Genetics will never feel the same.
12/12/24 • 27:16
Polycystic kidney disease, multicystic kidney disease, kidney cancer risk, kidney failure risk, exploding brain arteries risk. Join us on our next podcast with Roman Ulrich-Müller and explore with us the vagaries and uncertainties of polycystic kidney disease. You can expect to hear about the difference between polycystic and multicystic kidney disease, how to diagnose PKD, when should we do genetic testing, and what can we get out of them, and much, much more. Join us.
12/12/24 • 31:40
The show producer has not yet provided a description for this episode.
12/5/24 • 01:09
The show producer has not yet provided a description for this episode.
12/5/24 • 00:32
The show producer has not yet provided a description for this episode.
12/5/24 • 00:35
Molecules and pathways come to mind, but solutions seem elusive. That’s why we’re bringing you an insightful episode from A Pinch of Salt on vascular calcification and calciphylaxis, featuring renowned specialists Smeeta Sinha. Join her as she guides you through the intricate pathways of this challenging topic in a dynamic, engaging discussion.
11/14/24 • 22:27
Disasters are an unavoidable part of life, whether caused by nature or human actions. The impact of a disaster, however, often depends on our level of preparedness—a challenge when facing events we’ve never experienced before. Join us as we talk with Serhan Tuğlular, former Chair of the ERA’s Kidney Relief in Disasters Task Force, who shares insights on how to better prepare and minimize devastation. This is a conversation that could save lives—don’t miss it!
11/14/24 • 26:29
In this episode we explore the unique challenges of pregnancy and kidney disease with guest Matt Hall, a leading expert in maternal medicine and obstetric nephrology. Hall shares insights into the latest advancements in supporting women with CKD who wish to start a family. Don’t miss this essential conversation!
11/14/24 • 31:04
The show producer has not yet provided a description for this episode.
11/7/24 • 01:17
The show producer has not yet provided a description for this episode.
11/7/24 • 00:45
The show producer has not yet provided a description for this episode.
11/7/24 • 01:10
National and international renal registries have significantly diversified their activities in recent years. The ERA Registry is committed to a wide range of population-based research activities. With extensive accumulated experience and a top-class staff, it is engaged in numerous research projects, cohort studies, and other scientific initiatives. Alberto Ortiz is the Chair of the ERA Registry Committee and is involved in groundbreaking research projects, including assistance with coding and definitions, as well as the EQUAL study. Check it out!
10/10/24 • 21:18
CKD-MBD can be a most confusing field. When we start learning about it, we are usually focused on lowering PTH levels, only to find out that in many scenarios high PTH levels are the consequence of PTH resistance and that overactivity of PTH might not even be the issue. But maybe PTH is not what we should be focusing on, maybe it’s phosphate and yet, how do we lower that efficiently? Treatment with vitamin D can lower PTH and increase phosphate. But at the end of the day, laboratory results might not be the main problem, maybe we should really focus on vascular calcifications? It’s complicated. We tried to untangle these dilemmas with Mathias Haarhaus, the current Chair of the CKD-MBD Working Group, in our new Podcast on CKD-MBD. Learn how to take care of your patients from someone with a lot of experience. It will certainly help.
10/10/24 • 24:32
People say that dinosaurs are extinct but apparently, that is not the case. You see, there are some of us who grew up and learned about nephrology in different times, times with no internet, no smartphone, no social media. A time that we might now refer to as the golden age, while others, who are younger and with far better skin, will refer to it as the age of dinosaurs. If you are one of these, likely to roar in frustration when opening one social media platform or the other, we have a podcast just for you. Meet Samira Farouk, a trail blazing social media nephrologist and much more, who will try to teach us dinosaurs how to tackle the jungle of social media. There’s stuff out there in the jungle that you might want to know about. Check out the new podcast - Social media in nephrology, a crash course, with Samira Farouk, only on A Pinch of Salt.
10/10/24 • 32:43
The show producer has not yet provided a description for this episode.
10/3/24 • 01:24
The show producer has not yet provided a description for this episode.
10/3/24 • 01:07
The show producer has not yet provided a description for this episode.
10/3/24 • 01:02
The more time is passing, the more we find the importance and the density of the functional interconnections between the kidney and the heart. If you treat one of them, you might potentially improve the other and the number of therapeutic agents with combined cardiorenal efficacy ever increases. We will have the honor and the pleasure of discussing cardiorenal medicine with Patrick Mark from the University of Glasgow, United Kingdom. A specialist on this matter in a most exciting session registered face to face during the ERA Stockholm Congress. Do not hesitate to join us on this fascinating journey of interconnection between the kidney and the heart.
9/12/24 • 23:31
You don’t know what you’ve got till it’s gone. Wise words from Joni Mitchell that you might find in her famous song Big Yellow Taxi. People who have never had problems sleeping have absolutely no idea how difficult life becomes when you can’t sleep properly or well enough. It’s literally a nightmare, only you're awake, and it seems like it lasts forever. Unfortunately, this nightmare is incredibly common in CKD patients, particularly in patients with end-stage kidney disease. It’s up to us to identify these patients, because if we don’t do it, it’s unlikely others will. We owe it to them because nowadays we have therapies that can work and help people sleep again. Let’s help people sleep again. Do you want to know how? Learn how to tackle sleep disorders in the podcast with Mark Unruh, a leading expert in sleep disorders in patients with CKD. Who knows, maybe this information will help your life at some point.
9/12/24 • 31:00
Being a young doctor must be one of the toughest positions a person can find themselves in. The key to success in medicine is experience which is the one thing you cannot have as a young doctor. That is why having a mentor, or mentors is essential. However, being in contact with your peers is also important. Sharing trials and tribulations with someone your own age is not only comforting but also informative. The world is a global place and contact with young professionals around Europe might be just the thing you need. That’s why we would like to encourage you, dear young nephrologist, to become an active member of the Young Nephrologists’ Platform: the YNP. Find out how you can join the numerous projects available, to gain new experiences, to grow as a person and as a doctor. Have a listen to our new podcast with Orsolya Cseprekál, the current Chair of the YNP to find out more.
9/12/24 • 18:25
The show producer has not yet provided a description for this episode.
9/5/24 • 00:53
The show producer has not yet provided a description for this episode.
9/5/24 • 01:17
The show producer has not yet provided a description for this episode.
9/5/24 • 01:10
Let's start with a quiz. Which was the most research in the World on Google for 2023? Yes, of course. Artificial intelligence. A super hot topic. Things are going ready fast, and the text, the videos, the images, the books but what about the medicine? What about the nephrology? Is it coming? Is it already here? If you want to know more about it, check us out in the ERA podcast with Roser Torra, ERA President coming from Fundació Puigvert, Spain.
6/13/24 • 16:52
Most of us have gone to medical universities to become doctors, and physicians, to be the people who diagnose and treat patients. At some point, however, we all realize that we’re also the ones that are supposed to do the medical research which does not come naturally to many of us. If you can relate to what has just been said, we have the right answers for you, ladies and gentlemen. Have a listen to our new ERA podcast with the editors of NDT and CKJ, Hans-Joachim Anders and Jürgen Floege. Listen to them being honest about what kind of research they would like to see in journals and how to make your work more presentable. The amount of pearls shared could fill a whole necklace. You don’t believe me? Check it out.
6/13/24 • 35:46
Every nephrologist knows about serum creatinine, eGFR, albuminuria, proteinuria. We use them to assess disease activity. But do we really assess disease activity with them? eGFR can be low and albuminuria or proteinuria can be high because of chronic and potentially irreversible changes, like glomerulosclerosis and tubulointerstitial fibrosis, changes that might not be amenable to treatment. How do we know which patient needs more treatment if what we are picking up with established markers might be fibrosis. Well, these questions might become old-fashioned quickly. Let us introduce you to DKK3, a new urine biomarker which could finally identify patients with ongoing kidney injury that might benefit from more treatment. Have a listen to our new ERA podcast with Danilo Fliser, explaining what DKK3 is and why we should all probably begin measuring it.
6/13/24 • 18:10
